Amgen Inc. (AMGN)
NASDAQ: AMGN
· Real-Time Price · USD
297.89
0.49 (0.16%)
At close: Oct 03, 2025, 3:59 PM
297.92
0.01%
After-hours: Oct 03, 2025, 07:53 PM EDT
Repatha (evolocumab) Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 696M | 40M | +6.10% |
| Mar 31, 2025 | 656M | 50M | +8.25% |
| Dec 31, 2024 | 606M | 39M | +6.88% |
| Sep 30, 2024 | 567M | 35M | +6.58% |
| Jun 30, 2024 | 532M | 15M | +2.90% |
| Mar 31, 2024 | 517M | n/a | n/a |
| Dec 31, 2023 | n/a | n/a | n/a |
| Sep 30, 2023 | n/a | n/a | n/a |
| Jun 30, 2023 | n/a | n/a | n/a |
| Mar 31, 2023 | n/a | n/a | n/a |
| Dec 31, 2022 | n/a | n/a | n/a |
| Sep 30, 2022 | n/a | n/a | n/a |
| Jun 30, 2022 | n/a | n/a | n/a |
| Mar 31, 2022 | n/a | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2021 | n/a | n/a | n/a |
| Jun 30, 2021 | n/a | n/a | n/a |
| Mar 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2020 | n/a | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2019 | n/a | n/a | n/a |
| Jun 30, 2019 | n/a | n/a | n/a |
| Mar 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2018 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |